FR2947729B1 - Composition pharmaceutique pour le traitement du diabete de type ii par voie trans-muqueuse buccale - Google Patents
Composition pharmaceutique pour le traitement du diabete de type ii par voie trans-muqueuse buccaleInfo
- Publication number
- FR2947729B1 FR2947729B1 FR0954819A FR0954819A FR2947729B1 FR 2947729 B1 FR2947729 B1 FR 2947729B1 FR 0954819 A FR0954819 A FR 0954819A FR 0954819 A FR0954819 A FR 0954819A FR 2947729 B1 FR2947729 B1 FR 2947729B1
- Authority
- FR
- France
- Prior art keywords
- mucosal
- diabetes
- treatment
- type
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0954819A FR2947729B1 (fr) | 2009-07-10 | 2009-07-10 | Composition pharmaceutique pour le traitement du diabete de type ii par voie trans-muqueuse buccale |
IN977DEN2012 IN2012DN00977A (fr) | 2009-07-10 | 2010-07-07 | |
PCT/FR2010/051426 WO2011004117A1 (fr) | 2009-07-10 | 2010-07-07 | Procédé et compositions pharmaceutiques pour le traitement de l'hyper glycémie post-prandiale du diabète de type ii par voie trans-muqueuse buccale |
JP2012519040A JP2012532852A (ja) | 2009-07-10 | 2010-07-07 | 2型糖尿病における食後高血糖の経頬粘膜治療の方法、および当該治療に用いられる医薬組成物 |
EP10742210A EP2451436A1 (fr) | 2009-07-10 | 2010-07-07 | Procédé et compositions pharmaceutiques pour le traitement de l'hyper glycémie post-prandiale du diabète de type ii par voie trans-muqueuse buccale |
US13/383,101 US9161910B2 (en) | 2009-07-10 | 2010-07-07 | Method and pharmaceutical compositions for trans-buccal mucosa treatment of postprandial hyperglycaemia in type II diabetes |
MX2012000466A MX337606B (es) | 2009-07-10 | 2010-07-07 | Metodo y composiciones farmaceuticas para el tratamiento de la hiperglicemia postprandial de la diabetes tipo ii, a traves de la mucosa bucal. |
RU2012104639/15A RU2543635C2 (ru) | 2009-07-10 | 2010-07-07 | Способ и фармацевтические композиции для лечения постпрандиальной гипергликемии диабета ii типа введением через слизистую ротовой полости |
BR112012000596A BR112012000596A2 (pt) | 2009-07-10 | 2010-07-07 | processo e composições farmacêuticas para o tratamento de hiperglicemia pós-prandial de diabetes tipo ii por via transmucosa bucal |
CN2010800381696A CN102481254A (zh) | 2009-07-10 | 2010-07-07 | 用于通过颊透粘膜途径来治疗ii 型糖尿病的餐后高血糖的方法和药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0954819A FR2947729B1 (fr) | 2009-07-10 | 2009-07-10 | Composition pharmaceutique pour le traitement du diabete de type ii par voie trans-muqueuse buccale |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2947729A1 FR2947729A1 (fr) | 2011-01-14 |
FR2947729B1 true FR2947729B1 (fr) | 2012-01-20 |
Family
ID=41571558
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0954819A Expired - Fee Related FR2947729B1 (fr) | 2009-07-10 | 2009-07-10 | Composition pharmaceutique pour le traitement du diabete de type ii par voie trans-muqueuse buccale |
Country Status (10)
Country | Link |
---|---|
US (1) | US9161910B2 (fr) |
EP (1) | EP2451436A1 (fr) |
JP (1) | JP2012532852A (fr) |
CN (1) | CN102481254A (fr) |
BR (1) | BR112012000596A2 (fr) |
FR (1) | FR2947729B1 (fr) |
IN (1) | IN2012DN00977A (fr) |
MX (1) | MX337606B (fr) |
RU (1) | RU2543635C2 (fr) |
WO (1) | WO2011004117A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2940116B1 (fr) * | 2008-12-22 | 2012-07-06 | Philippe Perovitch | Formulation pour l'administration d'hypolipemiant par voie trans-muqueuse buccale |
FR3000896B1 (fr) * | 2013-01-14 | 2016-08-26 | Philippe Perovitch | Forme galenique pour l'administration de principe(s) actif(s) permettant l'induction acceleree du sommeil et/ou le traitement des troubles du sommeil |
FR3031668A1 (fr) | 2015-01-20 | 2016-07-22 | Philippe Perovitch | Dispositif d'administration d'un principe actif par voie per-muqueuse buccale. |
FR3053244A1 (fr) | 2016-07-01 | 2018-01-05 | Philippe Perovitch | Dispositif d'administration d'au moins un principe actif par voie per-muqueuse buccale. |
CN107669683B (zh) * | 2017-09-30 | 2020-07-03 | 杭州华东医药集团新药研究院有限公司 | 含有西格列汀与二甲双胍的药物组合物 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2071779C1 (ru) * | 1993-05-12 | 1997-01-20 | Хабаровский химико-фармацевтический завод | Способ получения пантокрина для инъекций |
US20030095925A1 (en) * | 1997-10-01 | 2003-05-22 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders |
US6451286B1 (en) * | 1998-12-21 | 2002-09-17 | Generex Pharmaceuticals Incorporated | Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds |
US20030087820A1 (en) * | 1999-01-14 | 2003-05-08 | Young Andrew A. | Novel exendin agonist formulations and methods of administration thereof |
US20030235595A1 (en) * | 1999-06-30 | 2003-12-25 | Feng-Jing Chen | Oil-containing, orally administrable pharmaceutical composition for improved delivery of a therapeutic agent |
US7411089B2 (en) * | 2002-04-15 | 2008-08-12 | Ajinomoto Co., Inc. | Nateglinide crystals |
SE528866C2 (sv) * | 2005-07-01 | 2007-02-27 | Volvo Lastvagnar Ab | Anordning för att kontrollera höjden hos en last eller lastbärare bakom förarhytten hos en lastbil |
NZ591609A (en) * | 2005-08-30 | 2012-10-26 | Abbott Lab | Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
DE102006027790A1 (de) * | 2006-06-16 | 2007-12-20 | Lts Lohmann Therapie-Systeme Ag | Typ-2-Diabetes Kombinations-Wafer |
JP2009544715A (ja) * | 2006-07-28 | 2009-12-17 | ノヴァデル ファーマ インコーポレイテッド | 抗片頭痛の口腔噴霧製剤及び方法 |
FR2906140B1 (fr) | 2006-09-22 | 2008-12-05 | Philippe Perovitch | Forme galenique pour l'administration par voie trans-muqueuse de principes actifs |
-
2009
- 2009-07-10 FR FR0954819A patent/FR2947729B1/fr not_active Expired - Fee Related
-
2010
- 2010-07-07 EP EP10742210A patent/EP2451436A1/fr not_active Withdrawn
- 2010-07-07 US US13/383,101 patent/US9161910B2/en not_active Expired - Fee Related
- 2010-07-07 WO PCT/FR2010/051426 patent/WO2011004117A1/fr active Application Filing
- 2010-07-07 BR BR112012000596A patent/BR112012000596A2/pt not_active IP Right Cessation
- 2010-07-07 MX MX2012000466A patent/MX337606B/es active IP Right Grant
- 2010-07-07 CN CN2010800381696A patent/CN102481254A/zh active Pending
- 2010-07-07 JP JP2012519040A patent/JP2012532852A/ja active Pending
- 2010-07-07 RU RU2012104639/15A patent/RU2543635C2/ru not_active IP Right Cessation
- 2010-07-07 IN IN977DEN2012 patent/IN2012DN00977A/en unknown
Also Published As
Publication number | Publication date |
---|---|
IN2012DN00977A (fr) | 2015-04-10 |
JP2012532852A (ja) | 2012-12-20 |
MX337606B (es) | 2016-03-10 |
CN102481254A (zh) | 2012-05-30 |
FR2947729A1 (fr) | 2011-01-14 |
WO2011004117A1 (fr) | 2011-01-13 |
US9161910B2 (en) | 2015-10-20 |
BR112012000596A2 (pt) | 2016-02-10 |
EP2451436A1 (fr) | 2012-05-16 |
MX2012000466A (es) | 2012-04-19 |
RU2543635C2 (ru) | 2015-03-10 |
RU2012104639A (ru) | 2013-08-20 |
US20120190618A1 (en) | 2012-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201200551A1 (ru) | Фармацевтическая композиция, фармацевтическая дозированная форма, способы их получения и применения для лечения | |
FR2960542B1 (fr) | Peptide en tant que medicament, en particulier pour le traitement du cancer | |
SMT201600055B (it) | Composizione farmaceutica per il trattamento o la prevenzione del glaucoma | |
FR2948016B1 (fr) | Orthese pour le traitement de la rhizarthrose | |
IN2014MN00948A (fr) | ||
BRPI1012116A2 (pt) | composição farmacêutica para o tratamento de doenças cardíacas | |
BR112013015622A2 (pt) | métodos de produção de composições farmacêuticas de dosagem sólida estabilizadas contendo morfinanos | |
EA201300137A1 (ru) | Комбинированная фармацевтическая композиция и способ лечения заболеваний или состояний, связанных с нейродегенеративными зоболеваниями | |
PL2429507T3 (pl) | Kompozycja farmaceutyczna wolna od fosforanów do leczenia jaskry | |
EE201300004A (et) | Kombineeritud ravimkoostis sdame-veresoonkonnaga seotud haiguste v?i seisundite raviks | |
FR2947729B1 (fr) | Composition pharmaceutique pour le traitement du diabete de type ii par voie trans-muqueuse buccale | |
DE102009018133A8 (de) | Pharmazeutische Zusammensetzung zur Behandlung von dermatologischen Autoimmunerkrankungen | |
IT1397838B1 (it) | Composizione per la cura delle piante | |
FR2940116B1 (fr) | Formulation pour l'administration d'hypolipemiant par voie trans-muqueuse buccale | |
IL218001A0 (en) | Pharmaceutical composition for the treatment of mcp-1 mediated inflammatory diseases | |
FR2980976B1 (fr) | Composition pharmaceutique pour l'administration par voie nasale de la metopimazine | |
FR2953723B1 (fr) | Composition pharmaceutique destinee au traitement des pathologies orthopediques | |
FR2954699B1 (fr) | Composition pharmaceutique pour le traitement de la dependance a l'alcool | |
EP2402342A4 (fr) | Composition pharmaceutique servant a traiter le diabete de type 2 | |
FR2926722B1 (fr) | Formulation pharmaceutique appropriee pour la preparation de comprimes orodispersibles de prednisolone | |
FR2931072B1 (fr) | Composition emolliente pour le traitement preventif de la dermatite atopique | |
FR2953412B1 (fr) | Medicament pour le traitement des ulceres gastro-intestinaux | |
PH12015502560A1 (en) | Use of a thiazolo pyrimidinone for the treatment of inflammatory bowel disease | |
FR2978916B1 (fr) | Composition pharmaceutique solide pour administration buccale d'agomelatine | |
IT1399791B1 (it) | Composizioni farmaceutiche per il trattamento della poliposi nasale |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 7 |
|
PLFP | Fee payment |
Year of fee payment: 8 |
|
PLFP | Fee payment |
Year of fee payment: 9 |
|
PLFP | Fee payment |
Year of fee payment: 10 |
|
PLFP | Fee payment |
Year of fee payment: 11 |
|
ST | Notification of lapse |
Effective date: 20210305 |